Xanax

Xanax product details

Xanax contains alprazolam, an oral benzodiazepine indicated for acute treatment of generalized anxiety disorder and treatment of panic disorder, with or without agoraphobia, in adults. Immediate-release Xanax tablets and Xanax XR are different formulations. Symptom improvement can be accompanied by sedation and memory or coordination problems. Prescribers evaluate the role and duration of benzodiazepine treatment alongside the risks of dependence, drug interactions and the patient’s broader anxiety-treatment plan. Generic name alprazolam Brand names Xanax, Xanax XR (extended release) Drug class Benzodiazepine US federal status Schedule IV Available forms Immediate-release tablets: 0.25, 0.5, 1 and 2 mg.

How it works Alprazolam binds to benzodiazepine sites on GABA-A receptor complexes, enhancing the inhibitory effects of GABA. The resulting reduction in CNS activity can lessen anxiety but also produce sedation, impaired coordination and memory effects. This mechanism does not directly address every cause of anxiety or panic, and a sedating effect should not be confused with long-term disease control. Other CNS depressants act at overlapping functional pathways, explaining why combinations can be dangerous even when each medicine is prescribed.

Elimination half-life Mean about 11.2 hours; individual values vary widely Absorption & metabolism Alprazolam is absorbed orally and metabolized mainly through CYP3A enzymes in the liver. Its mean elimination half-life is roughly 11.2 hours, with substantial variation across individuals. Age, obesity, liver disease and interacting medicines may prolong exposure. Immediate-release and extended-release products differ in absorption pattern rather than becoming different active drugs. A person may feel less anxious for fewer hours than the drug remains in the body; redosing based only on a fading sensation can lead to accumulation. Common side effects Sedation, impaired coordination, lightheadedness.

Serious reactions & long-term concerns The boxed warning highlights profound sedation and respiratory depression with opioids, abuse and addiction, and potentially life-threatening withdrawal. Falls, impaired driving, cognitive effects and paradoxical agitation are additional concerns. Respiratory disease and exposure during late pregnancy create further risks requiring clinician review. Severe drowsiness, slowed breathing, loss of consciousness or seizures demand urgent help. Tolerance may develop to perceived benefit without equal tolerance to memory impairment, so a reduced subjective effect is not evidence that escalation is safe.

Call 911 for slowed or stopped breathing, inability to wake, seizure, collapse, or severe allergic swelling. If an opioid overdose is suspected, give naloxone if available and follow its instructions while emergency help is on the way. Xanax vs Valium Both alprazolam and diazepam enhance GABA-A signaling, but diazepam has a longer terminal half-life and long-lived active metabolites. Alprazolam has adult panic-disorder approval; diazepam has additional muscle-spasm, alcohol-withdrawal and adjunctive seizure indications. Longer persistence may increase accumulation and delayed impairment, while shorter persistence does not eliminate withdrawal risk. Neither drug is inherently safe with alcohol or opioids. Differences in metabolism, age, liver function and indication matter more than an assumed stronger-versus-weaker ranking; conversion or tapering requires a clinician.